FDA approves new Bristol Myers Squibb schizophrenia drug [Yahoo! Finance Canada]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance Canada
drug, making it the first new drug-related approach for the disease in 30 years. Morning Brief Hosts Seana Smith and Madison Mills report more on the story and dig into how the drug works. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Melanie Riehl Video Transcript Bristol Myers Squibb shares surging the FDA approving the pharmaceutical giant Schizophrenia drug making it the first new drug related approach for the disease in 30 years, you can see those shares up over 3%. Right now. The drug to be available in late October 3 million people have schizophrenia, but only about half of them are medicated, Shana. So I thought that was interesting, just the potential degree of growth that could come as people hopefully get more access to the pills. Yeah. And I think one of the pushbacks from people who have been prescribed these pills is some of the side effects. So the fact that th
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol Myers Squibb stock rises following FDA approval of its schizophrenia drug [CNBC]CNBC
- New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder [FOX News]FOX News
- BMS wins approval for schizophrenia drug acquired from Karuna [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Stock Up on FDA Nod for Schizophrenia Treatment [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb Presents New Data from Two Trials Demonstrating Sotyktu (deucravacitinib) Efficacy in both Moderate-to-Severe Scalp Psoriasis and in a Real-World Setting [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 7/26/24 - Beat
BMY
Sec Filings
- 8/5/24 - Form 4
- 7/31/24 - Form 4
- 7/31/24 - Form 3/A
- BMY's page on the SEC website